Skip to content

Ranking Member's Press

 Expand
Skip to page number selection

Press releases from: June 2022

Published
Burr, Foxx Demand Clarity on Biden’s Statutory Authority on Student Loan Repayment Freeze, Forgiveness
Published
Senator Burr Statement on Vote Against FDA User Fee Agreement Package
Published
Senators Burr, Casey Introduce College Savings Recovery Act
Published
Burr: FDA User Fee Agreements Advance Innovation, Bring Important Reforms Following Infant Formula Crisis

Press releases from: May 2022

Published
Burr Demands Accountability from Biden Admin on Telework Management, Productivity
Published
Senators Burr, Murray Introduce Bill to Support FDA Programs to Lower Costs and Spur Innovation
Published
Key Takeaways from Senate HELP Hearing on FDA’s Role in Infant Formula Shortage
Published
Burr: When Will the FDA Take Accountability for Failure on Infant Formula Crisis?
Published
Burr, Senators Call for Senate Appropriations Committee to Double CCDBG Funding in Five Years
Published
Burr, Foxx Again Call Out Department of Education for Its Lack of Cooperation on Facebook Student Data Privacy Leak
Published
Burr Releases Timeline Detailing FDA, Biden Admin Failures in Infant Formula Crisis
Published
Burr, Colleagues Introduce Bill to Stop President Biden from Canceling Student Loan Debt
Published
Burr, Senators Submit Comment to Biden Labor Department Opposing Misleading Efforts to Rewrite Davis-Bacon
Published
Senators Burr, Murray Release Legislation to Support FDA Programs to Lower Costs and Spur Innovation
Published
Senator Burr Demands Accountability from FDA on Infant Formula Crisis
Published
Senator Burr Statement on Conference for U.S. Innovation and Competition Act of 2021
Published
Burr Leads Letter Calling Out Brazen, Unilateral Attempt by IRS to Expand Obamacare Subsidies
Published
Burr, Foxx Demand Accountability from Department of Education on Facebook Student Data Privacy Leak
Published
Burr Questions Biden EEOC Nominee’s Lack of Impartiality, Commitment to Transparency

Press releases from: April 2022

Published
Burr: FDA Must Be Held Accountable to Meeting Terms of Its Commitments in User Fee Programs